Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gal Markel

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Human Immunology|November 7, 2003
Special organization of the HLA-G protein on the cell surfaceTsufit Gonen-Gross, Roi Gazit, Hagit Achdout, et al.
Frontiers in Immunology|October 26, 2017
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 SeparationSivan Seliktar-Ofir, Efrat Merhavi-Shoham, Orit Itzhaki, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patientsGuy Ben-Betzalel, Yael Steinberg-Silman, Ronen Stoff, et al.
The Israel Medical Association Journal : IMAJ|December 17, 2008
Medical management of toxicological mass casualty eventsGal Markel, Amir Krivoy, Eran Rotman, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2025
Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalationItamar Averbuch, Nofar Edri, Nethanel Asher, et al.
Cancers|July 2, 2021
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical ExperienceNethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1Noam Stern, Gal Markel, Tal I Arnon, et al.
The Journal of Clinical Investigation|October 9, 2002
Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functionsGal Markel, Dana Wolf, Jacob Hanna, et al.
American Journal of Perinatology|August 1, 2014
Pilot study of a new mathematical algorithm for early detection of late-onset sepsis in very low-birth-weight infantsIlan Gur, Arieh Riskin, Gal Markel, et al.
Neoplasia (New York, N.Y.)|March 21, 2018
Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma CellsKarin Kfir-Elirachman, Rona Ortenberg, Bella Vizel, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Human Immunology|November 7, 2003
Special organization of the HLA-G protein on the cell surfaceTsufit Gonen-Gross, Roi Gazit, Hagit Achdout, et al.
Frontiers in Immunology|October 26, 2017
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 SeparationSivan Seliktar-Ofir, Efrat Merhavi-Shoham, Orit Itzhaki, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patientsGuy Ben-Betzalel, Yael Steinberg-Silman, Ronen Stoff, et al.
The Israel Medical Association Journal : IMAJ|December 17, 2008
Medical management of toxicological mass casualty eventsGal Markel, Amir Krivoy, Eran Rotman, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2025
Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalationItamar Averbuch, Nofar Edri, Nethanel Asher, et al.
Cancers|July 2, 2021
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical ExperienceNethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1Noam Stern, Gal Markel, Tal I Arnon, et al.
The Journal of Clinical Investigation|October 9, 2002
Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functionsGal Markel, Dana Wolf, Jacob Hanna, et al.
American Journal of Perinatology|August 1, 2014
Pilot study of a new mathematical algorithm for early detection of late-onset sepsis in very low-birth-weight infantsIlan Gur, Arieh Riskin, Gal Markel, et al.
Neoplasia (New York, N.Y.)|March 21, 2018
Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma CellsKarin Kfir-Elirachman, Rona Ortenberg, Bella Vizel, et al.
Pageof 14